Description: Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. It also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. The company's products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Cetilar Tape, Cetilar Oro, Cetilar Nutrition, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. It distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. The company was founded in 2003 and is based in Pisa, Italy.
Home Page: www.pharmanutra.it
Via Campodavela 1
Pisa,
PI
56122
Italy
Phone:
39 05 07 84 65 00
Officers
| Name | Title |
|---|---|
| Mr. Andrea Lacorte | Chairman & President |
| Mr. Roberto Lacorte | Vice Chairman, MD & VP |
| Mr. Carlo Volpi | Delegate Advisor, COO & Executive Director |
| Mr. Germano Tarantino | Scientific Director & Executive Director |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 32.3669 |
| Price-to-Book MRQ: | 8.9236 |
| Price-to-Sales TTM: | 4.9198 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 112 |